• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Identification and validation of SRC and phospho-SRC family proteins in circulating mononuclear cells as novel biomarkers for pancreatic cancer.鉴定和验证循环单核细胞中的 SRC 和磷酸化 SRC 家族蛋白作为胰腺癌的新型生物标志物。
Transl Oncol. 2011 Apr 1;4(2):83-91. doi: 10.1593/tlo.10202.
2
Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCEL), a multi-targeted kinase inhibitor.磷酸化SRC的鉴定与验证,一种针对多靶点激酶抑制剂达沙替尼(施达赛)的新型潜在药效学生物标志物。
Cancer Chemother Pharmacol. 2008 Nov;62(6):1065-74. doi: 10.1007/s00280-008-0699-5. Epub 2008 Feb 27.
3
Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib.鉴定在达沙替尼治疗后用于测量结肠癌细胞中Src激酶活性抑制作用的潜在生物标志物。
Mol Cancer Ther. 2006 Dec;5(12):3014-22. doi: 10.1158/1535-7163.MCT-06-0382. Epub 2006 Dec 5.
4
Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.在原位裸鼠模型中,抑制SRC的表达和活性可抑制人胰腺腺癌细胞的肿瘤进展和转移。
Am J Pathol. 2006 Mar;168(3):962-72. doi: 10.2353/ajpath.2006.050570.
5
Targeting the yin and the yang: combined inhibition of the tyrosine kinase c-Src and the tyrosine phosphatase SHP-2 disrupts pancreatic cancer signaling and biology in vitro and tumor formation in vivo.针对阴阳:联合抑制酪氨酸激酶 c-Src 和酪氨酸磷酸酶 SHP-2 可破坏体外胰腺癌信号和生物学以及体内肿瘤形成。
Pancreas. 2013 Jul;42(5):795-806. doi: 10.1097/MPA.0b013e3182793fd7.
6
Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.通过二维凝胶电泳和质谱法检测,与正常胰腺组织及受胰腺炎影响的组织相比,胰腺腺癌中的蛋白质表达谱。
Cancer Res. 2004 Dec 15;64(24):9018-26. doi: 10.1158/0008-5472.CAN-04-3262.
7
Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.天冬氨酸 β-羟化酶通过激活 SRC 信号通路促进胰腺导管腺癌转移。
J Hematol Oncol. 2019 Dec 30;12(1):144. doi: 10.1186/s13045-019-0837-z.
8
A novel nuclear Src and p300 signaling axis controls migratory and invasive behavior in pancreatic cancer.一种新型核Src和p300信号轴控制胰腺癌的迁移和侵袭行为。
Oncotarget. 2016 Feb 9;7(6):7253-67. doi: 10.18632/oncotarget.6635.
9
C-Src confers resistance to mitotic stress through inhibition DMAP1/Bub3 complex formation in pancreatic cancer.C-Src 通过抑制 DMAP1/Bub3 复合物的形成赋予胰腺癌细胞对有丝分裂应激的抗性。
Mol Cancer. 2018 Dec 15;17(1):174. doi: 10.1186/s12943-018-0919-5.
10
Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts.Src/Abl抑制剂博舒替尼(SKI-606)在新生成的人胰腺癌异种移植模型中的疗效和药效学作用
Mol Cancer Ther. 2009 Jun;8(6):1484-93. doi: 10.1158/1535-7163.MCT-09-0075. Epub 2009 Jun 9.

引用本文的文献

1
Functional roles of SRC signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities.SRC 信号在胰腺癌中的功能作用:最新研究进展为其提供了新的治疗机会。
Oncogene. 2023 Jun;42(22):1786-1801. doi: 10.1038/s41388-023-02701-x. Epub 2023 Apr 29.
2
Pancreatic Cancer and Its Microenvironment-Recent Advances and Current Controversies.胰腺癌及其微环境:最新进展与当前争议
Int J Mol Sci. 2020 May 1;21(9):3218. doi: 10.3390/ijms21093218.
3
The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?利用循环肿瘤细胞鉴定去势抵抗性前列腺癌耐药机制的前景:上皮-间质转化是关键因素吗?
Prostate Cancer. 2020 Mar 30;2020:7938280. doi: 10.1155/2020/7938280. eCollection 2020.
4
Targeting the complexity of Src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy.靶向胰腺癌肿瘤微环境中Src 信号的复杂性:从机制到治疗。
FEBS J. 2019 Sep;286(18):3510-3539. doi: 10.1111/febs.15011. Epub 2019 Aug 5.
5
Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.吉西他滨增强纳米载体结合白蛋白紫杉醇在吉西他滨耐药性胰腺导管腺癌中的转运。
Cancer Lett. 2017 Sep 10;403:296-304. doi: 10.1016/j.canlet.2017.06.026. Epub 2017 Jul 4.
6
Interplay of Matrix Stiffness and c-SRC in Hepatic Fibrosis.肝纤维化中基质硬度与c-SRC的相互作用
Front Physiol. 2015 Dec 2;6:359. doi: 10.3389/fphys.2015.00359. eCollection 2015.
7
pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma.循环肿瘤细胞中的磷酸化细胞外信号调节激酶/磷酸化蛋白激酶B表型分析作为晚期肝细胞癌患者索拉非尼疗效的生物标志物
Oncotarget. 2016 Jan 19;7(3):2646-59. doi: 10.18632/oncotarget.6104.
8
Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer cells.新型喹唑啉二酮类氧化还原调节剂QD232对胰腺癌细胞的细胞毒性作用机制
Br J Pharmacol. 2015 Jan;172(1):50-63. doi: 10.1111/bph.12855.
9
Pancreatic cancer risk in hereditary pancreatitis.遗传性胰腺炎患者患胰腺癌的风险
Front Physiol. 2014 Feb 20;5:70. doi: 10.3389/fphys.2014.00070. eCollection 2014.
10
Src as the link between inflammation and cancer.Src作为炎症与癌症之间的联系。
Front Physiol. 2014 Jan 16;4:416. doi: 10.3389/fphys.2013.00416. eCollection 2013.

本文引用的文献

1
Pancreatic cancer: current and future treatment strategies.胰腺癌:当前及未来的治疗策略
Cancer Treat Rev. 2009 Aug;35(5):431-6. doi: 10.1016/j.ctrv.2009.02.005. Epub 2009 Mar 27.
2
Origins and tissue-context-dependent fates of blood monocytes.血液单核细胞的起源及组织背景依赖性命运
Immunol Cell Biol. 2009 Jan;87(1):30-8. doi: 10.1038/icb.2008.90. Epub 2008 Dec 2.
3
Preoperative evaluation of pancreatic adenocarcinoma.胰腺腺癌的术前评估
J Hepatobiliary Pancreat Surg. 2008;15(4):429-35. doi: 10.1007/s00534-007-1240-7. Epub 2008 Aug 1.
4
The role of myeloid cells in the promotion of tumour angiogenesis.髓样细胞在促进肿瘤血管生成中的作用。
Nat Rev Cancer. 2008 Aug;8(8):618-31. doi: 10.1038/nrc2444. Epub 2008 Jul 17.
5
Role of myeloid cells in tumor angiogenesis and growth.髓系细胞在肿瘤血管生成和生长中的作用。
Trends Cell Biol. 2008 Aug;18(8):372-8. doi: 10.1016/j.tcb.2008.06.003. Epub 2008 Jul 7.
6
Regulation of phagocyte migration and recruitment by Src-family kinases.Src家族激酶对吞噬细胞迁移和募集的调控。
Cell Mol Life Sci. 2008 Jul;65(14):2175-90. doi: 10.1007/s00018-008-8005-6.
7
Mining the plasma proteome for cancer biomarkers.挖掘血浆蛋白质组以寻找癌症生物标志物。
Nature. 2008 Apr 3;452(7187):571-9. doi: 10.1038/nature06916.
8
Detection of oncogenes in chronic pancreatitis.慢性胰腺炎中癌基因的检测
HPB (Oxford). 2003;5(4):214-25. doi: 10.1080/13651820310017804.
9
Identification of new regional marker proteins to map mouse brain by 2-D difference gel electrophoresis screening.通过二维差异凝胶电泳筛选鉴定用于绘制小鼠脑图谱的新区域标记蛋白。
Electrophoresis. 2008 Apr;29(7):1518-24. doi: 10.1002/elps.200700487.
10
Cancer statistics, 2008.2008年癌症统计数据。
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.

鉴定和验证循环单核细胞中的 SRC 和磷酸化 SRC 家族蛋白作为胰腺癌的新型生物标志物。

Identification and validation of SRC and phospho-SRC family proteins in circulating mononuclear cells as novel biomarkers for pancreatic cancer.

机构信息

Department of Cancer Biology, Cancer Metastasis Research Center, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Transl Oncol. 2011 Apr 1;4(2):83-91. doi: 10.1593/tlo.10202.

DOI:10.1593/tlo.10202
PMID:21461171
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3069651/
Abstract

There is an urgent need to develop novel markers of pancreatic cancer to facilitate early diagnosis. Pancreatic carcinoma is characterized by marked stroma formation with a high number of infiltrating tumor-associated macrophages (TAMs) that originate from circulating mononuclear cells (MNCs). We hypothesized that differential analysis of protein expression and phosphorylation in circulating MNCs from healthy nude mice and nude mice bearing orthotopic human pancreatic cancer would identify a surrogate marker of pancreatic cancer. These differences were analyzed by two-dimensional gel electrophoresis followed by Western blot analysis using antibody against phosphorylated tyrosine proteins (pY). Protein and phosphorylated protein spots of interest were identified by mass spectrometry and validated by Western blot analysis as candidate markers for pancreatic cancer. We found that the expression and phosphorylation of Src family proteins were significantly higher in circulating MNCs from mice bearing pancreatic cancer than in circulating MNCs from healthy mice. TAMs in mice with pancreatic tumors also had higher Src family protein expression and phosphorylation than resident macrophages in the pancreas of healthy mice. The expression and phosphorylation of Src family proteins were correlated with tumor weight; however, increased Src expression and phosphorylation also occurred in MNCs from mice with chronic pancreatitis. This is the first report to explore novel pancreatic tumor markers in circulating MNCs. Although the specificity of the marker for pancreatic cancer was low, it could be used to monitor the disease or to select high-risk patients with chronic pancreatitis.

摘要

目前迫切需要开发新的胰腺癌标志物,以促进早期诊断。胰腺癌的特征是基质形成明显,浸润的肿瘤相关巨噬细胞(TAMs)数量众多,这些 TAMs 来源于循环单核细胞(MNC)。我们假设对来自健康裸鼠和荷人原位胰腺癌裸鼠的循环 MNC 中的蛋白质表达和磷酸化进行差异分析,将鉴定出胰腺癌的替代标志物。使用针对磷酸化酪氨酸蛋白(pY)的抗体通过二维凝胶电泳和 Western blot 分析来分析这些差异。通过质谱鉴定感兴趣的蛋白质和磷酸化蛋白质斑点,并通过 Western blot 分析进行验证,作为胰腺癌的候选标志物。我们发现,与健康小鼠的循环 MNC 相比,荷胰腺癌小鼠的循环 MNC 中 Src 家族蛋白的表达和磷酸化显著升高。胰腺肿瘤小鼠的 TAMs 中 Src 家族蛋白的表达和磷酸化也高于健康小鼠胰腺中的固有巨噬细胞。Src 家族蛋白的表达和磷酸化与肿瘤重量相关;然而,慢性胰腺炎小鼠的 MNC 中也出现了 Src 表达和磷酸化的增加。这是首次在循环 MNC 中探索新型胰腺肿瘤标志物的报道。尽管该标志物对胰腺癌的特异性较低,但它可用于监测疾病或选择慢性胰腺炎的高危患者。